MoonLake Immunotherapeutics company logo
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) Cash From Financing

Annual CFF

$51.31M$428.39M-89.30%

Summary

Current Value
As of today, MLTX annual cash from financing is $51.31M, down -89.30% on
Historical Performance
MLTX annual cash from financing is up +18.60% over the past 3 years, and down -56.01% over the past 5 years
All-Time High Comparison
MLTX annual cash from financing is currently -89.30% below its historical high of $479.70M set on
3-Year Low Comparison
MLTX annual cash from financing is at its 3-year low
Sector Comparison
MLTX annual cash from financing is higher than 74.85% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MLTX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$51.31M-89.3%+18.6%-56.0%-56.0%
Quarterly Cash From Financing$480.00K+162.2%+100.0%
TTM Cash From Financing$73.75M-7.3%-45.2%
Price$18.49-61.6%+52.9%+60.8%
Annual Cash From Operations-$116.59M-172.5%-231.4%-10000.0%-10000.0%
Annual Cash From Investing-$205.60M-716.4%-10000.0%-78.8%-78.8%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$2.83M-23.5%-81.1%+4770.2%+4770.2%
Shares Outstanding70.85M+12.3%+81.8%+493.9%

Cash From Financing Highs

MLTX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$479.70M-89.3%
5Y$479.70M-89.3%
All$479.70M-89.3%

Cash From Financing Lows

MLTX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$51.31Mat low
5Y$43.26M+18.6%
All$43.26M+18.6%

Cash From Financing History

YearValueChange
$51.31M-89.3%
$479.70M+300.8%
$119.69M+176.7%
YearValueChange
$43.26M-62.9%
$116.65M-

FAQ

  • What is the current annual cash from financing of MLTX?

    As of today, MLTX annual cash from financing is $51.31M

  • What is 1-year change in MLTX annual cash from financing?

    MLTX annual cash from financing is down -89.30% year-over-year

  • What is 3-year change in MLTX annual cash from financing?

    MLTX annual cash from financing is up +18.60% over the past 3 years

  • How far is MLTX annual cash from financing from its all-time high?

    MLTX annual cash from financing is currently -89.30% below its historical high of $479.70M set on December 31, 2023

  • How does MLTX annual cash from financing rank versus sector peers?

    MLTX annual cash from financing is higher than 74.85% of companies in Healthcare sector

  • When is MLTX next annual earnings release?

    The next annual earnings release for MLTX is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. MLTX Official Website www.moonlaketx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1821586/000182158625000022/0001821586-25-000022-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821586/000182158625000006/0001821586-25-000006-index.htm
  4. MLTX Profile on Yahoo Finance finance.yahoo.com/quote/MLTX
  5. MLTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mltx